首页 > 最新文献

Wiener medizinische Wochenschrift最新文献

英文 中文
Clinical and epidemiologic characteristics of hospitalized oncological patients with hypercalcemia: a longitudinal, multicenter study. 住院肿瘤患者高钙血症的临床和流行病学特征:一项纵向多中心研究。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-01 Epub Date: 2024-07-23 DOI: 10.1007/s10354-024-01051-x
Guillermo Ropero-Luis, Jaime Sanz-Cánovas, Almudena López-Sampalo, Alberto Ruiz-Cantero, Ricardo Gómez-Huelgas

Background: There are few studies that have analyzed the characteristics of hypercalcemia in hospitalized oncological patients. Our objectives were to describe the clinical characteristics of hospitalized patients with paraneoplastic hypercalcemia and to identify prognostic variables for mortality.

Methods: This was an observational, longitudinal, retrospective, and bicentric study. It included adult patients admitted to two hospitals in Málaga, Spain (2014-2018). The minimum follow-up period was 2 years or until death.

Results: A total of 154 patients were included; the majority (71.4%) were admitted to the internal medicine department. The median follow-up was 3.5 weeks (interquartile range [IQR] 1.1-11.5). The mean (standard deviation) age was 67.6 (12.3) years, with a predominance of males (58.4%). The median (IQR) serum calcium at admission was 13.2 (11.8-14.6) mg/dl. The most common neoplasms were pulmonary (27.3%), hematologic (23.4%), urological (13%), and breast (12.3%). Furthermore, 56.5% of cases had a known history of neoplasia at the time of diagnosis. The parathyroid hormone (PTH) level was determined in 24%; of these, 10.8% had elevated levels. In all, 95.5% of patients died during follow-up. The median survival was 3.4 weeks (95% confidence interval 2.6-4.3). Factors associated with higher mortality were age, serum calcium at admission, previous history of neoplasia, etiology other than multiple myeloma, and noncorrection of hypercalcemia.

Conclusions: In hospitalized patients, paraneoplastic hypercalcemia was associated with high short-term mortality. Several factors associated with a worse prognosis were identified in these patients.

背景:分析住院肿瘤患者高钙血症特征的研究很少。我们的目标是描述副肿瘤性高钙血症住院患者的临床特征,并确定死亡率的预后变量:这是一项观察性、纵向、回顾性双中心研究。研究对象包括西班牙马拉加两家医院收治的成年患者(2014-2018年)。最短随访期为2年或直至死亡:共纳入 154 名患者,其中大部分(71.4%)在内科住院。随访中位数为 3.5 周(四分位数间距 [IQR] 1.1-11.5)。平均(标准差)年龄为 67.6(12.3)岁,男性占多数(58.4%)。入院时血清钙的中位数(IQR)为 13.2 (11.8-14.6) mg/dl。最常见的肿瘤是肺癌(27.3%)、血液肿瘤(23.4%)、泌尿肿瘤(13%)和乳腺癌(12.3%)。此外,56.5%的病例在诊断时已知有肿瘤病史。24%的患者接受了甲状旁腺激素(PTH)水平测定,其中10.8%的患者PTH水平升高。95.5%的患者在随访期间死亡。中位生存期为 3.4 周(95% 置信区间为 2.6-4.3)。死亡率较高的相关因素包括年龄、入院时血清钙、既往肿瘤病史、多发性骨髓瘤以外的病因以及未纠正高钙血症:结论:在住院患者中,副肿瘤性高钙血症与较高的短期死亡率有关。结论:在住院患者中,副肿瘤性高钙血症与较高的短期死亡率有关。
{"title":"Clinical and epidemiologic characteristics of hospitalized oncological patients with hypercalcemia: a longitudinal, multicenter study.","authors":"Guillermo Ropero-Luis, Jaime Sanz-Cánovas, Almudena López-Sampalo, Alberto Ruiz-Cantero, Ricardo Gómez-Huelgas","doi":"10.1007/s10354-024-01051-x","DOIUrl":"10.1007/s10354-024-01051-x","url":null,"abstract":"<p><strong>Background: </strong>There are few studies that have analyzed the characteristics of hypercalcemia in hospitalized oncological patients. Our objectives were to describe the clinical characteristics of hospitalized patients with paraneoplastic hypercalcemia and to identify prognostic variables for mortality.</p><p><strong>Methods: </strong>This was an observational, longitudinal, retrospective, and bicentric study. It included adult patients admitted to two hospitals in Málaga, Spain (2014-2018). The minimum follow-up period was 2 years or until death.</p><p><strong>Results: </strong>A total of 154 patients were included; the majority (71.4%) were admitted to the internal medicine department. The median follow-up was 3.5 weeks (interquartile range [IQR] 1.1-11.5). The mean (standard deviation) age was 67.6 (12.3) years, with a predominance of males (58.4%). The median (IQR) serum calcium at admission was 13.2 (11.8-14.6) mg/dl. The most common neoplasms were pulmonary (27.3%), hematologic (23.4%), urological (13%), and breast (12.3%). Furthermore, 56.5% of cases had a known history of neoplasia at the time of diagnosis. The parathyroid hormone (PTH) level was determined in 24%; of these, 10.8% had elevated levels. In all, 95.5% of patients died during follow-up. The median survival was 3.4 weeks (95% confidence interval 2.6-4.3). Factors associated with higher mortality were age, serum calcium at admission, previous history of neoplasia, etiology other than multiple myeloma, and noncorrection of hypercalcemia.</p><p><strong>Conclusions: </strong>In hospitalized patients, paraneoplastic hypercalcemia was associated with high short-term mortality. Several factors associated with a worse prognosis were identified in these patients.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"38-44"},"PeriodicalIF":1.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duration of umbilical venous catheterization in neonatal care: balancing benefits and risks for improved outcomes. 新生儿护理中脐静脉导管插入术的持续时间:平衡收益与风险,改善预后。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-01 Epub Date: 2024-10-31 DOI: 10.1007/s10354-024-01061-9
Muhammad Eeman Bhutta, Muhammad Hammad Siddique, Fasi Ur Rehman Bhutta, Ajla Fatima
{"title":"Duration of umbilical venous catheterization in neonatal care: balancing benefits and risks for improved outcomes.","authors":"Muhammad Eeman Bhutta, Muhammad Hammad Siddique, Fasi Ur Rehman Bhutta, Ajla Fatima","doi":"10.1007/s10354-024-01061-9","DOIUrl":"10.1007/s10354-024-01061-9","url":null,"abstract":"","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"400-401"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic and treatment possibilities in the management of positional plagiocephaly. 位置性头颅畸形的诊断和治疗方法。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-01 Epub Date: 2024-10-22 DOI: 10.1007/s10354-024-01056-6
Robert Chrenko, Andrej Plž, Barbora Nedomová, Dana Kuniaková

Positional plagiocephaly, characterized by an asymmetric skull shape, is the most common craniofacial malformation in infancy. Associated risk factors include a preference for the supine position, first and assisted delivery, multiple pregnancy, prematurity, and congenital muscular torticollis. The diagnosis is established by clinical and anthropometric examinations. In the case of moderate or severe deformity, three-dimensional optical scanning enables a detailed depiction of the deformity and provides a safe and noninvasive tool for follow-up. Treatment mainly includes repositioning of the infant, while orthotic therapy is considered in cases of severe deformity. Cranial orthotic therapy is most effective when started between 4 and 7 months of age. The total duration of orthotic treatment ranges from 2 to 6 months. Although the clinical course of positional plagiocephaly is generally benign and the prognosis favorable, its increasing prevalence has prompted the development of novel diagnostic and therapeutic strategies over the past decade.

位置性头颅骨不对称是婴儿期最常见的颅面畸形。相关的危险因素包括喜欢仰卧位、头胎分娩和助产分娩、多胎妊娠、早产和先天性肌肉扭曲症。诊断需要通过临床和人体测量检查来确定。对于中度或重度畸形,三维光学扫描可详细描述畸形情况,并为后续治疗提供安全、无创的工具。治疗主要包括婴儿的复位,而在严重畸形的情况下则考虑矫形治疗。颅骨矫形治疗在婴儿 4 到 7 个月大时开始最有效。矫形治疗的总疗程为 2 到 6 个月。虽然位置性头颅畸形的临床表现通常是良性的,预后良好,但在过去的十年中,其发病率的不断上升促使人们不断开发新的诊断和治疗策略。
{"title":"Diagnostic and treatment possibilities in the management of positional plagiocephaly.","authors":"Robert Chrenko, Andrej Plž, Barbora Nedomová, Dana Kuniaková","doi":"10.1007/s10354-024-01056-6","DOIUrl":"10.1007/s10354-024-01056-6","url":null,"abstract":"<p><p>Positional plagiocephaly, characterized by an asymmetric skull shape, is the most common craniofacial malformation in infancy. Associated risk factors include a preference for the supine position, first and assisted delivery, multiple pregnancy, prematurity, and congenital muscular torticollis. The diagnosis is established by clinical and anthropometric examinations. In the case of moderate or severe deformity, three-dimensional optical scanning enables a detailed depiction of the deformity and provides a safe and noninvasive tool for follow-up. Treatment mainly includes repositioning of the infant, while orthotic therapy is considered in cases of severe deformity. Cranial orthotic therapy is most effective when started between 4 and 7 months of age. The total duration of orthotic treatment ranges from 2 to 6 months. Although the clinical course of positional plagiocephaly is generally benign and the prognosis favorable, its increasing prevalence has prompted the development of novel diagnostic and therapeutic strategies over the past decade.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"394-399"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of mean platelet volume for diagnosing esophagitis in children with gastroesophageal reflux disease. 平均血小板体积对诊断患有胃食管反流病的儿童食管炎的价值。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-01 Epub Date: 2024-11-18 DOI: 10.1007/s10354-024-01062-8
Azin Gouran, Mohammadreza Esmaeili Dooki, Hossein-Ali Nikbakht, Hassan Mahmoodi, Mohammad Pornasrolah, Maryam Nikpour, Sanaz Mehrabani

Background: The prevalence of gastroesophageal reflux disease (GERD) in children is increasing in different societies. This study aims to investigate the value of mean platelet volume (MPV) for diagnosing esophagitis in children with GERD.

Methods: This cross-sectional study conducted at Amirkola Children's Hospital between 2022 and 2023 involved children aged 2 to 16 years diagnosed with GERD. The diagnosis was based on the GSQ-YC and GASP‑Q questionnaires. All patients underwent endoscopy, with a biopsy for pathology and a blood sample for MPV analysis. The data were then analyzed using SPSS software version 22 (IBM Corp., Armonk, NY, USA), with a significance level set at lower than 0.05.

Results: The frequency of esophagitis among 194 participants was 39.7%. The overall sensitivity and specificity of MPV for diagnosing esophagitis in children were 64.63% and 52.14%, respectively (area under the curve [AUC] = 0.59). In terms of gender, the overall sensitivity and specificity of the MPV were 85.00% and 32.65% in boys and 70.27% and 51.47% in girls (AUC = 0.58 and AUC = 0.61, respectively). In terms of age, the overall sensitivity and specificity of MPV in children under 12 years were 52.46% and 62.26% and in children older than 12 years 87.5% and 36.36% (AUC = 0.58 and AUC = 0.55, respectively).

Conclusion: In summary, the results of this study indicate that MPV is not a reliable method for diagnosing esophagitis in children with GERD.

背景:在不同的社会中,儿童胃食管反流病(GERD)的发病率正在上升。本研究旨在探讨平均血小板体积(MPV)对诊断胃食管反流病儿童食管炎的价值:这项横断面研究于 2022 年至 2023 年期间在 Amirkola 儿童医院进行,涉及确诊为胃食管反流病的 2 至 16 岁儿童。诊断依据是 GSQ-YC 和 GASP-Q 问卷。所有患者都接受了内窥镜检查,并进行了病理活检和血液样本 MPV 分析。然后使用 SPSS 软件 22 版(IBM Corp., Armonk, NY, USA)对数据进行分析,显著性水平设定为低于 0.05:194名参与者中食管炎的发生率为39.7%。MPV 诊断儿童食管炎的总体灵敏度和特异度分别为 64.63% 和 52.14%(曲线下面积 [AUC] = 0.59)。在性别方面,男孩 MPV 的总体灵敏度和特异性分别为 85.00% 和 32.65%,女孩为 70.27% 和 51.47%(AUC = 0.58 和 AUC = 0.61)。就年龄而言,12 岁以下儿童 MPV 的总体灵敏度和特异性分别为 52.46% 和 62.26%,12 岁以上儿童的总体灵敏度和特异性分别为 87.5% 和 36.36%(AUC = 0.58 和 AUC = 0.55):总之,本研究结果表明,MPV 不是诊断胃食管反流患儿食管炎的可靠方法。
{"title":"Value of mean platelet volume for diagnosing esophagitis in children with gastroesophageal reflux disease.","authors":"Azin Gouran, Mohammadreza Esmaeili Dooki, Hossein-Ali Nikbakht, Hassan Mahmoodi, Mohammad Pornasrolah, Maryam Nikpour, Sanaz Mehrabani","doi":"10.1007/s10354-024-01062-8","DOIUrl":"10.1007/s10354-024-01062-8","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of gastroesophageal reflux disease (GERD) in children is increasing in different societies. This study aims to investigate the value of mean platelet volume (MPV) for diagnosing esophagitis in children with GERD.</p><p><strong>Methods: </strong>This cross-sectional study conducted at Amirkola Children's Hospital between 2022 and 2023 involved children aged 2 to 16 years diagnosed with GERD. The diagnosis was based on the GSQ-YC and GASP‑Q questionnaires. All patients underwent endoscopy, with a biopsy for pathology and a blood sample for MPV analysis. The data were then analyzed using SPSS software version 22 (IBM Corp., Armonk, NY, USA), with a significance level set at lower than 0.05.</p><p><strong>Results: </strong>The frequency of esophagitis among 194 participants was 39.7%. The overall sensitivity and specificity of MPV for diagnosing esophagitis in children were 64.63% and 52.14%, respectively (area under the curve [AUC] = 0.59). In terms of gender, the overall sensitivity and specificity of the MPV were 85.00% and 32.65% in boys and 70.27% and 51.47% in girls (AUC = 0.58 and AUC = 0.61, respectively). In terms of age, the overall sensitivity and specificity of MPV in children under 12 years were 52.46% and 62.26% and in children older than 12 years 87.5% and 36.36% (AUC = 0.58 and AUC = 0.55, respectively).</p><p><strong>Conclusion: </strong>In summary, the results of this study indicate that MPV is not a reliable method for diagnosing esophagitis in children with GERD.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"387-393"},"PeriodicalIF":1.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tinea pseudoimbricata: a narrative literature review and five new cases. 假肢癣:文献综述和五个新病例。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-01 Epub Date: 2024-11-27 DOI: 10.1007/s10354-024-01065-5
Anca Chiriac, Pietro Nenoff, Uwe Wollina

Background: Tinea pseudoimbricata is a variant of tinea incognito, with multiple erythematous concentric rings (ring in a ring) and pruritus. Misuse of topical corticosteroids is a major exogenous factor.

Objective: We provide an overview of published cases and report the first case series from Romania.

Patients and methods: A narrative review of the literature was conducted in PubMed and amended by ResearchGate. A series of pediatric cases from Romania with clinical suspicion of tinea pseudoimbricata was investigated by clinical examination, KOH preparations of skin scrapings, and mycological culture when possible.

Results: We collected 137 cases of tinea pseudoimbricata from the literature and added a series of 5 pediatric patients from Romania. Oral treatment with fluconazole was effective in all of them. Worldwide, most reports came from India (86%), 3.5% were from other Asian countries, 3.5% were from the Americas, and 7% were from Europe. M. canis and T. mentagrophytes were identified in 2 patients from Romania. T. mentagrophytes, T. rubrum, and T. tonsurans are the dominant species worldwide, but molecular diagnostics were available for only a minor part of cases.

Conclusion: Tinea pseudoimbricata is most common in India. This is the first case series on tinea pseudoimbricata from Romania. Tinea pseudoimbricata is an emerging disease in Europe. Identification of fungi has rarely been done by molecular mycology. This may have caused an overestimation of T. mentagrophytes and an underestimation of T. indotineae.

背景:假环状癣菌是真菌性癣菌的变种,具有多发性红斑同心环(环中环)和瘙痒。滥用外用皮质类固醇激素是主要的外源性因素:我们概述了已发表的病例,并报告了罗马尼亚的首例系列病例:我们在 PubMed 上对文献进行了叙述性综述,并通过 ResearchGate 进行了修改。通过临床检查、皮肤刮片的 KOH 制剂以及可能的真菌培养,对罗马尼亚临床怀疑患有假丝酵母癣的一系列儿科病例进行了调查:结果:我们从文献中收集了 137 例假丝状癣菌病例,并增加了罗马尼亚的 5 例儿科患者。氟康唑口服治疗对所有病例均有效。从世界范围来看,大多数报告来自印度(86%),3.5%来自其他亚洲国家,3.5%来自美洲,7%来自欧洲。在罗马尼亚的 2 名患者中发现了犬毛癣菌和脑膜炎双球菌。曼陀罗癣菌、红癣菌和扁平苔藓癣菌是全球主要的癣菌种,但只有一小部分病例可以进行分子诊断:结论:假丝癣在印度最为常见。这是罗马尼亚的首例假肢癣病系列病例。假肢癣菌病在欧洲是一种新出现的疾病。真菌鉴定很少采用分子真菌学方法。这可能导致高估了T. mentagrophytes,低估了T. indotineae。
{"title":"Tinea pseudoimbricata: a narrative literature review and five new cases.","authors":"Anca Chiriac, Pietro Nenoff, Uwe Wollina","doi":"10.1007/s10354-024-01065-5","DOIUrl":"10.1007/s10354-024-01065-5","url":null,"abstract":"<p><strong>Background: </strong>Tinea pseudoimbricata is a variant of tinea incognito, with multiple erythematous concentric rings (ring in a ring) and pruritus. Misuse of topical corticosteroids is a major exogenous factor.</p><p><strong>Objective: </strong>We provide an overview of published cases and report the first case series from Romania.</p><p><strong>Patients and methods: </strong>A narrative review of the literature was conducted in PubMed and amended by ResearchGate. A series of pediatric cases from Romania with clinical suspicion of tinea pseudoimbricata was investigated by clinical examination, KOH preparations of skin scrapings, and mycological culture when possible.</p><p><strong>Results: </strong>We collected 137 cases of tinea pseudoimbricata from the literature and added a series of 5 pediatric patients from Romania. Oral treatment with fluconazole was effective in all of them. Worldwide, most reports came from India (86%), 3.5% were from other Asian countries, 3.5% were from the Americas, and 7% were from Europe. M. canis and T. mentagrophytes were identified in 2 patients from Romania. T. mentagrophytes, T. rubrum, and T. tonsurans are the dominant species worldwide, but molecular diagnostics were available for only a minor part of cases.</p><p><strong>Conclusion: </strong>Tinea pseudoimbricata is most common in India. This is the first case series on tinea pseudoimbricata from Romania. Tinea pseudoimbricata is an emerging disease in Europe. Identification of fungi has rarely been done by molecular mycology. This may have caused an overestimation of T. mentagrophytes and an underestimation of T. indotineae.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"340-345"},"PeriodicalIF":1.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142733132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lichen planus-the role of age and gender in clinical appearance and treatment : A narrative review. 扁平苔藓--年龄和性别在临床表现和治疗中的作用 :叙述性综述。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-01 Epub Date: 2024-11-12 DOI: 10.1007/s10354-024-01057-5
Uwe Wollina, André Koch, Monika Fida, Anca Chiriac, Abdulkarim Hasan, Ayman Abdelmaksoud

Lichen planus is a common pruritic inflammatory disorder of the skin with an autoimmune background. It affects < 1% of the general population. The disease has significant comorbidities that must be considered in a holistic approach. Skin and skin adnexa, mucosa, eyes, and the esophagus may be affected. There are various clinical subtypes in addition to classical cutaneous lichen planus. These subtypes depend on age and gender. Nail involvement can result in functional and psychological impairment. Lichen planopilaris in adults leads to irreversible cicatrical alopecia. Erosive and ulcerated lichen planus of the mucosa carries an increased risk of malignant transformation, at least in adults. Treatment must consider the affected area, the severity of disease, age, gender, and comorbidities.

扁平苔藓是一种常见的瘙痒性皮肤炎症,具有自身免疫背景。它影响
{"title":"Lichen planus-the role of age and gender in clinical appearance and treatment : A narrative review.","authors":"Uwe Wollina, André Koch, Monika Fida, Anca Chiriac, Abdulkarim Hasan, Ayman Abdelmaksoud","doi":"10.1007/s10354-024-01057-5","DOIUrl":"10.1007/s10354-024-01057-5","url":null,"abstract":"<p><p>Lichen planus is a common pruritic inflammatory disorder of the skin with an autoimmune background. It affects < 1% of the general population. The disease has significant comorbidities that must be considered in a holistic approach. Skin and skin adnexa, mucosa, eyes, and the esophagus may be affected. There are various clinical subtypes in addition to classical cutaneous lichen planus. These subtypes depend on age and gender. Nail involvement can result in functional and psychological impairment. Lichen planopilaris in adults leads to irreversible cicatrical alopecia. Erosive and ulcerated lichen planus of the mucosa carries an increased risk of malignant transformation, at least in adults. Treatment must consider the affected area, the severity of disease, age, gender, and comorbidities.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"311-330"},"PeriodicalIF":1.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired digital periungual fibrokeratoma in a 36-year-old male: case report and an update. 36岁男性获得性指趾周围纤维角化瘤病例报告及最新进展。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-01 Epub Date: 2025-03-10 DOI: 10.1007/s10354-025-01073-z
G Tchernev, D Linkwinstar, A Shine, V Broshtilova, S Kordeva

Acquired digital fibrokeratoma (ADFK) is a rare benign mesenchymal tumor often presenting as a small, firm, hyperkeratotic lesion, typically located in the periungual or subungual regions of the digits. Though benign, ADFK can lead to significant functional or cosmetic issues and may be mistaken for more serious conditions such as squamous cell carcinoma or pyogenic granuloma. We report the case of a 36-year-old male with a 3- to 4‑year history of a progressively enlarging periungual tumor leading to nail deformity and mild pressure effects on the underlying bone. The patient's history included minor trauma, possibly contributing to the lesion's development. Dermatological and histopathological evaluations revealed a well-demarcated mesenchymal lesion with orthohyperkeratosis, irregular acanthosis, and stellate fibroblasts within a vascular stroma, consistent with ADFK. A CT scan confirmed mild deformity of the distal phalanx but no bone infiltration. Surgical excision was offered but deferred by the patient, who preferred monitoring of the lesion. This case highlights the importance of accurate diagnosis through clinical, histopathological, and imaging evaluations to distinguish ADFK from other periungual tumors and underscores the need for individualized treatment based on patient preferences and the lesion's impact.

获得性指纤维角化瘤(ADFK)是一种罕见的良性间质肿瘤,通常表现为小而坚硬的角化过度病变,通常位于趾周或趾下区域。虽然是良性的,但ADFK会导致严重的功能或美容问题,并可能被误认为是更严重的疾病,如鳞状细胞癌或化脓性肉芽肿。我们报告一个36岁的男性病例,他有3到4年的甲周进行性扩大的肿瘤病史,导致指甲畸形和对底层骨的轻微压力作用。患者的病史包括轻微创伤,这可能导致病变的发展。皮肤病学和组织病理学检查显示间充质病变伴正角化过度,棘层不规则,血管间质内有星状成纤维细胞,与ADFK一致。CT扫描证实远端指骨轻度畸形,但未见骨浸润。手术切除,但推迟了病人,谁更愿意监测病变。该病例强调了通过临床、组织病理学和影像学评估来准确诊断ADFK与其他甲周肿瘤的重要性,并强调了根据患者偏好和病变影响进行个体化治疗的必要性。
{"title":"Acquired digital periungual fibrokeratoma in a 36-year-old male: case report and an update.","authors":"G Tchernev, D Linkwinstar, A Shine, V Broshtilova, S Kordeva","doi":"10.1007/s10354-025-01073-z","DOIUrl":"10.1007/s10354-025-01073-z","url":null,"abstract":"<p><p>Acquired digital fibrokeratoma (ADFK) is a rare benign mesenchymal tumor often presenting as a small, firm, hyperkeratotic lesion, typically located in the periungual or subungual regions of the digits. Though benign, ADFK can lead to significant functional or cosmetic issues and may be mistaken for more serious conditions such as squamous cell carcinoma or pyogenic granuloma. We report the case of a 36-year-old male with a 3- to 4‑year history of a progressively enlarging periungual tumor leading to nail deformity and mild pressure effects on the underlying bone. The patient's history included minor trauma, possibly contributing to the lesion's development. Dermatological and histopathological evaluations revealed a well-demarcated mesenchymal lesion with orthohyperkeratosis, irregular acanthosis, and stellate fibroblasts within a vascular stroma, consistent with ADFK. A CT scan confirmed mild deformity of the distal phalanx but no bone infiltration. Surgical excision was offered but deferred by the patient, who preferred monitoring of the lesion. This case highlights the importance of accurate diagnosis through clinical, histopathological, and imaging evaluations to distinguish ADFK from other periungual tumors and underscores the need for individualized treatment based on patient preferences and the lesion's impact.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"358-362"},"PeriodicalIF":1.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143597915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features of RUNX1-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBioPortal). 国家(ABCMML)和国际队列(cBioPortal)中runx1突变的慢性髓细胞白血病患者的特征
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 Epub Date: 2025-03-26 DOI: 10.1007/s10354-025-01074-y
Sarah Bayat, Klaus Geissler

Big data collected in large international cooperations now allow validation of findings from traditional national patient cohorts for proving consistency. In this study, we compared findings in RUNX1-mutated patients of the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) with the CMML cohort documented in cBioPortal. In the cBioPortal cohort, RUNX1-mutated patients had significantly inferior survival and AML-free survival as compared to nonmutated patients. In the ABCMML cohort, survival and AML-free survival were numerically shorter in RUNX1-mutated patients than in wildtype patients, but this did not reach significance. Regarding phenotype, in both cohorts, RUNX1-mutated patients had a significantly higher proportion of patients with thrombocytopenia and lower metric values for platelets as compared to wildtype patients. Validation of data, as we have done in this study in CMML patients using two independent cohorts, ensures the quality standards that are required for their use in clinical decision making.

在大型国际合作中收集的大数据现在允许验证来自传统国家患者队列的发现,以证明一致性。在这项研究中,我们比较了奥地利慢性骨髓单核细胞白血病(ABCMML)生物数据库中runx1突变患者的发现与cBioPortal中记录的CMML队列。在cBioPortal队列中,与非突变患者相比,runx1突变患者的生存期和无aml生存期明显较差。在ABCMML队列中,runx1突变患者的生存期和无aml生存期在数值上短于野生型患者,但这并没有达到显著性。关于表型,在两个队列中,与野生型患者相比,runx1突变患者的血小板减少患者比例明显更高,血小板度量值也较低。正如我们在本研究中使用两个独立队列对CMML患者所做的那样,数据验证确保了在临床决策中使用所需的质量标准。
{"title":"Features of RUNX1-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBioPortal).","authors":"Sarah Bayat, Klaus Geissler","doi":"10.1007/s10354-025-01074-y","DOIUrl":"10.1007/s10354-025-01074-y","url":null,"abstract":"<p><p>Big data collected in large international cooperations now allow validation of findings from traditional national patient cohorts for proving consistency. In this study, we compared findings in RUNX1-mutated patients of the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) with the CMML cohort documented in cBioPortal. In the cBioPortal cohort, RUNX1-mutated patients had significantly inferior survival and AML-free survival as compared to nonmutated patients. In the ABCMML cohort, survival and AML-free survival were numerically shorter in RUNX1-mutated patients than in wildtype patients, but this did not reach significance. Regarding phenotype, in both cohorts, RUNX1-mutated patients had a significantly higher proportion of patients with thrombocytopenia and lower metric values for platelets as compared to wildtype patients. Validation of data, as we have done in this study in CMML patients using two independent cohorts, ensures the quality standards that are required for their use in clinical decision making.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"296-301"},"PeriodicalIF":1.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143731552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of NRAS-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and an international cohort (cBioPortal). 国家(ABCMML)和国际队列(cBioPortal)中nras突变的慢性髓细胞白血病患者的特征
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 Epub Date: 2025-05-15 DOI: 10.1007/s10354-025-01080-0
Alexandra Qian, Klaus Geissler

Big data from large international cooperations allow proving consistency of findings in national patient cohorts. We compared features in NRAS-mutated patients of the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) with the chronic myelomonocytic leukemia (CMML) cohort documented in cBioPortal. It is consistently demonstrated in both CMML cohorts that NRAS mutations are associated with shorter overall survival, acute myeloid leukemia-free survival, increased white blood cell count, decreased platelet values and the presence of blast cells in peripheral blood. Hemoglobin values did not differ between patients with or without NRAS mutations in either cohort. Validation of data in CMML patients using two independent cohorts, ensures the quality standards for clinical decision making.

来自大型国际合作的大数据可以证明国家患者队列研究结果的一致性。我们比较了奥地利慢性骨髓单核细胞白血病(ABCMML)生物数据库中nras突变患者与cBioPortal中记录的慢性骨髓单核细胞白血病(CMML)队列的特征。在两个CMML队列中一致证明,NRAS突变与较短的总生存期、急性髓系无白血病生存期、白细胞计数增加、血小板值降低和外周血中母细胞的存在相关。在两个队列中,有或没有NRAS突变的患者的血红蛋白值没有差异。使用两个独立队列验证CMML患者的数据,确保临床决策的质量标准。
{"title":"Characteristics of NRAS-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and an international cohort (cBioPortal).","authors":"Alexandra Qian, Klaus Geissler","doi":"10.1007/s10354-025-01080-0","DOIUrl":"10.1007/s10354-025-01080-0","url":null,"abstract":"<p><p>Big data from large international cooperations allow proving consistency of findings in national patient cohorts. We compared features in NRAS-mutated patients of the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) with the chronic myelomonocytic leukemia (CMML) cohort documented in cBioPortal. It is consistently demonstrated in both CMML cohorts that NRAS mutations are associated with shorter overall survival, acute myeloid leukemia-free survival, increased white blood cell count, decreased platelet values and the presence of blast cells in peripheral blood. Hemoglobin values did not differ between patients with or without NRAS mutations in either cohort. Validation of data in CMML patients using two independent cohorts, ensures the quality standards for clinical decision making.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"267-273"},"PeriodicalIF":1.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL). 国家(ABCMML)和国际队列(cBIOPORTAL)中tp53突变的慢性髓单细胞白血病患者的特征
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 Epub Date: 2025-03-05 DOI: 10.1007/s10354-025-01072-0
Magdalena Grass, Klaus Geissler

Big data collected in large international cooperations allow validation of findings from traditional national patient cohorts for proving consistency. In this study we analyzed outcomes and phenotypic features of TP53-mutated chronic myelomonocytic leukemia (CMML) patients in the Austrian biodatabase for CMML (ABCMML; n = 322) and in the international platform cBIOPORTAL (n = 399). The prevalences of TP53 mutations were 1.58 and 3.66, respectively. Numerically, overall survival was shorter in TP53-mutated patients in both cohorts (ABCMML 10.0 vs. 30.0 months and cBIOPORTAL 8.9 vs. 34.5 months), but this was statistically significant only in the cBIOPORTAL cohort. Decreased hemoglobin values and the presence of blast cells in peripheral blood were significantly associated with TP53 mutations in the cBIOPORTAL group but not in the ABCMML database. Our study indicates the necessity of sufficient patient numbers for the comparison of CMML patients regarding outcome and phenotype according to their molecular subtype, particularly in the case of rare mutations.

在大型国际合作中收集的大数据可以验证来自传统国家患者队列的发现,以证明一致性。在这项研究中,我们分析了奥地利CMML生物数据库中tp53突变的慢性髓细胞白血病(CMML)患者的结局和表型特征。n = 322)和国际平台cBIOPORTAL (n = 399)。TP53突变的患病率分别为1.58和3.66。数值上,两个队列中tp53突变患者的总生存期较短(ABCMML 10.0个月vs 30.0个月,cBIOPORTAL 8.9个月vs 34.5个月),但这仅在cBIOPORTAL队列中具有统计学意义。在cBIOPORTAL组中,血红蛋白值的降低和外周血中母细胞的存在与TP53突变显著相关,但在ABCMML数据库中没有。我们的研究表明,有必要根据分子亚型对CMML患者的预后和表型进行足够的患者数量的比较,特别是在罕见突变的情况下。
{"title":"Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL).","authors":"Magdalena Grass, Klaus Geissler","doi":"10.1007/s10354-025-01072-0","DOIUrl":"10.1007/s10354-025-01072-0","url":null,"abstract":"<p><p>Big data collected in large international cooperations allow validation of findings from traditional national patient cohorts for proving consistency. In this study we analyzed outcomes and phenotypic features of TP53-mutated chronic myelomonocytic leukemia (CMML) patients in the Austrian biodatabase for CMML (ABCMML; n = 322) and in the international platform cBIOPORTAL (n = 399). The prevalences of TP53 mutations were 1.58 and 3.66, respectively. Numerically, overall survival was shorter in TP53-mutated patients in both cohorts (ABCMML 10.0 vs. 30.0 months and cBIOPORTAL 8.9 vs. 34.5 months), but this was statistically significant only in the cBIOPORTAL cohort. Decreased hemoglobin values and the presence of blast cells in peripheral blood were significantly associated with TP53 mutations in the cBIOPORTAL group but not in the ABCMML database. Our study indicates the necessity of sufficient patient numbers for the comparison of CMML patients regarding outcome and phenotype according to their molecular subtype, particularly in the case of rare mutations.</p>","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"302-308"},"PeriodicalIF":1.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Wiener medizinische Wochenschrift
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1